The newly identified IGF2 variant indicates another molecular etiology for SRS beyond the hypomethylation of IC1, UPD7, and CDKN1C variants, which should be screened in SRS patients with negative regular molecular diagnosis results. This evidence concerns the gene CDKN1C and Silver-Russell syndrome.